US Patent Issued to Actuate Therapeutics on Sept. 22 for "Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3dioxolo[4,5-findol-7-yl)pyrrole-2,5-dione" (Chinese Inventor)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,973, issued on Sept. 22, was assigned to Actuate Therapeutics Inc. (Fort Worth, Texas).

"Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3dioxolo[4,5-findol-7-yl)pyrrole-2,5-dione" was invented by Yamin Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof in treating disease."

The patent was filed on Sept. 10, 2024, under Application No. 18/830,117.

*For further information, including images, charts...